Dr Kylee Maclachlan has been awarded a three-year fellowship in myeloma to Memorial Sloan Kettering Cancer Centre in New York City. Funding is required to assist Dr Maclachlan as she collaborates on an International trial that will bring novel therapies for the treatment of myeloma to Australia. The trial will also assist in developing protocols for assessing minimal residual disease to predict clinical outcome for myeloma patients. Kylee’s learnings will be brought back to Australia.
Seeking remaining Year 2 funding $17,500
Year 3 funding seeking $75,000